Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Science Advances|February 12, 2025
Targeted approach to determine the impact of cancer-associated protease variantsKira Bickenbach, Nele David, Tomas Koudelka, et al.Journal of Innate Immunity|January 17, 2015
Autoimmune disease-associated variants of extracellular endoplasmic reticulum aminopeptidase 1 induce altered innate immune responses by human immune cellsYasser A Aldhamen, Yuliya Pepelyayeva, David P W Rastall, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 28, 2012
A common single nucleotide polymorphism in endoplasmic reticulum aminopeptidase 2 induces a specificity switch that leads to altered antigen processingIrini Evnouchidou, James Birtley, Sergey Seregin, et al.Chembiochem : a European Journal of Chemical Biology|October 1, 2024
Covalent Labeling of Matrix Metalloproteases with Affinity-Based Probes Containing Tuned Reactive N-Acyl-N-Alkyl Sulfonamide Cleavable LinkersLaurent Devel, Carole Malgorn, Regis-William Tohon, et al.Scientific Reports|December 6, 2016
Optical imaging of MMP-12 active form in inflammation and aneurysmMahmoud Razavian, Thomas Bordenave, Dimitris Georgiadis, et al.Journal of Medicinal Chemistry|October 12, 2019
Novel Matrix Metalloproteinase 12 Selective Radiotracers for Vascular Molecular ImagingJakub Toczek, Thomas Bordenave, Kiran Gona, et al.Hypertension (Dallas, Tex. : 1979)|December 8, 2004
Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstrictionJoep H M van Esch, Beril Tom, Vincent Dive, et al.Bioconjugate Chemistry|August 27, 2016
Synthesis and in Vitro and in Vivo Evaluation of MMP-12 Selective Optical ProbesThomas Bordenave, Marion Helle, Fabrice Beau, et al.Angewandte Chemie (International Ed. in English)|June 7, 2021
Ligand-Directed Modification of Active Matrix Metalloproteases: Activity-based Probes with no Photolabile GroupMonika Kaminska, Pierrick Bruyat, Carole Malgorn, et al.Angewandte Chemie (International Ed. in English)|February 10, 2024
Discovery of the First-in-Class Inhibitors of Hypoxia Up-Regulated Protein 1 (HYOU1) Suppressing Pathogenic Fibroblast ActivationDimitra Papadopoulou, Vasiliki Mavrikaki, Filippos Charalampous, et al.Pageof 6